Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 5.74% | 16,609,007 |
| The Vanguard Group, Inc. | 4.86% | 14,064,639 |
| SSgA Funds Management, Inc. | 2.49% | 7,198,880 |
| Geode Capital Management LLC | 1.63% | 4,714,883 |
Similarly, What is Nio price target?
The 29 analysts offering 12-month price forecasts for NIO Inc have a median target of 32.94, with a high estimate of 86.57 and a low estimate of 24.08. The median estimate represents a +67.62% increase from the last price of 19.65.
Is BNGO an American company? Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. … The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Thereof, How many shares are there of BNGO?
BioNano Genomics Inc (US:BNGO) has 292 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,218,166 shares.
What sector is BNGO in?
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space.
Who owns the most Nio stock?
Top 10 Owners of NIO Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| Baillie Gifford & Co. | 5.76% | 88,858,365 |
| BlackRock Fund Advisors | 2.60% | 40,093,147 |
| The Vanguard Group, Inc. | 2.40% | 36,994,474 |
| SSgA Funds Management, Inc. | 2.13% | 32,887,731 |
Is it good to invest in Nio?
Investing in Nio today is best suited for investors willing to face extreme volatility and very high risk. However, the old saying that the greater the risk, the greater the reward holds true here. An investment in Nio is risky due to external factors beyond the company’s control.
How popular is Nio in China?
Shanghai-based Nio was founded in 2014 by William Li, a billionaire entrepreneur who got rich selling services to the auto industry. Nio currently sells three models and has a fourth on the way for early 2022. It’s delivered some 140,000 cars to customers in China and is expanding to Europe.
Who are Bionano genomics competitors?
13 Competitors
BioNano Genomics’s competitors are BioDiscovery, Fluxion Biosciences, IRX Therapeutics, Hepregen, Genvault Corporation and more.
How does Bionano genomics make money?
Revenue is produced by either directly selling the data to outsiders or by leveraging it for internal reasons, such as increasing the efficacy of advertising.
How many employees does BNGO have?
Compare BNGO With Other Stocks
| Bionano Genomics Annual Number of Employees | |
|---|---|
| 2020 | 147 |
| 2019 | 97 |
| 2018 | 77 |
| 2017 | 65 |
How much cash does BNGO have?
Bionano Genomics cash on hand from 2017 to 2021.
…
Compare BNGO With Other Stocks.
| Bionano Genomics Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2020 | $38 |
| 2019 | $17 |
| 2018 | $17 |
| 2017 | $1 |
Is BNGO in Russell?
(Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.
What is the short interest on BNGO?
Bionano Genomics currently has a short interest ratio of 5.0.
When did BNGO IPO?
The units are scheduled to begin trading on The Nasdaq Capital Market under the ticker symbol “BNGOU” on August 21, 2018, and the offering is expected to close on August 23, 2018, subject to customary closing conditions.
Who is in the vanguard group?
Vanguard offers two classes of most of its funds: investor shares and admiral shares.
…
The Vanguard Group.
| Type | Private |
|---|---|
| Key people | Mortimer J. Buckley (Chairman & CEO) |
| Products | Mutual funds Exchange-traded funds Broker Asset management Sub-advisory services |
| Revenue | $6.936 billion (2020) |
| AUM | $8.1 trillion (2022) |
Does Vanguard own NIO stock?
The top institutional shareholders of NIO are Originalwish Ltd., Tencent Holdings Ltd., Baillie Gifford & Co., BlackRock Inc. (BLK), and Vanguard Group Inc. Because NIO is a foreign company, it doesn’t file Form 4s for its individual insider shareholders.
What hedge funds hold NIO?
NIO (NYSE:NIO) Institutional Buying and Selling
| Reporting Date | Hedge Fund | Ownership in Company |
|---|---|---|
| 4/13/2022 | Redpoint Investment Management Pty Ltd | 0.002% |
| 4/12/2022 | Griffin Asset Management Inc. | 0.003% |
| 4/12/2022 | E Fund Management Hong Kong Co. Ltd. | 0.046% |
| 4/11/2022 | Nordea Investment Management AB | 0.081% |
Is NIO in danger of being delisted?
Your Takeaway on NIO Stock
Nio’s delisting risk is modest at this time. Investors should care more about the company’s path to profitability. When it gets there this year at the earliest, shareholders may hold the stock as it lists on an Asian exchange.
Who invested in NIO?
Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …
Will NIO come to the US?
The US branch of Chinese automaker NIO continues to make interesting moves in North America, as the company signed a ten year lease on a building in San Jose, CA. The new 200,000+ sq.
Join TheMoney.co community and don’t forget to share this post !